The federal government's escalating response to hospice fraud is moving from a hypothetical conversation about policy to concrete regulatory proposals that will affect every Medicare-enrolled hospice agency in the country. For legitimate providers, the message embedded in CMS's FY 2027 Hospice Wage Index and Payment Rate Update proposed rule represents both a warning and an opportunity.
Providers who have invested in quality, compliance, and transparent operations are about to be rewarded. Those who have not are about to find themselves under an uncomfortable spotlight.
The Fraud Crisis That Changed Everything
To understand why CMS is moving so aggressively, it helps to understand the scale of the problem driving its response. In California, a state with no Certificate of Need (CON) program governing hospice market entry, the supply of licensed hospice providers in Los Angeles County alone grew to more than 1,900 providers serving a population that by any reasonable analysis could support fewer than 300.
The result was systemic fraud at an industrial scale: fraudulent operators enrolled patients without terminal diagnoses, trafficked Medicare numbers between shell companies, and submitted claims for services never rendered. Federal officials estimate that fraud in LA County alone has reached $3.5 billion.
Ascendient recently examined this crisis in depth, exploring the role that CON regulations — or the lack of them — played in enabling this level of exploitation. That analysis concluded that the structured, need-based oversight CON provides serves as a critical front-end barrier against the market oversaturation that makes large-scale fraud possible. The California experience stands as one of the starker recent examples of what happens in its absence.
CMS has taken notice. The agency has conducted unannounced site visits nationwide, revoked or deactivated hundreds of provider enrollments, and expanded targeted oversight from its original four high-risk states (Arizona, California, Nevada, and Texas) to include Georgia, Ohio, and others.
The FY 2027 proposed rule carries that response further, extending the crackdown from enforcement actions into the permanent regulatory framework.
3 New Tools for Transparency and Accountability
The proposed rule introduces three mechanisms that together represent a fundamental shift in how regulators, consumers, and referral sources will evaluate hospice providers. Each one targets a specific vulnerability that fraud exploited in markets like California.
Public scoring system – CMS proposes to publish a Service and Spending Variation Index (SSVI) with a numerical score assigned to every Medicare-enrolled hospice, posted publicly on the CMS Hospice Center webpage. CMS will build the score from billing and utilization metrics including non-hospice spending for enrolled patients, the percentage of patients discharged alive after 180 or more days, average care minutes per day, and rates at which discharged patients return to the same hospice within a week.
None of these metrics alone constitutes proof of fraud, but collectively they capture the statistical patterns that characterized fraudulent operations in California: long lengths of stay, high live discharge rates, and low care intensity. For the first time, those patterns will now be publicly visible. CMS will flag facilities receiving high SSVI scores for additional regulatory review.
Care Compare compliance flag – Approximately 20% of hospices currently fail to meet federal quality reporting requirements under the Hospice Quality Reporting Program (HQRP). That gap in reporting has allowed providers to avoid public scrutiny of their performance – precisely the kind of opacity that enables poor quality and fraud to persist.
CMS proposes to flag non-compliant providers with a visible icon on its Care Compare consumer site, signaling to patients and families that sufficient quality data may not be available to assess that provider's performance. Providers who have filed on time and in good faith will gain a meaningful differentiator. Those who have not will carry a reputational liability visible to every prospective patient and family member who researches their options.
Mandatory patient disclosure – Currently, patients must actively request a document explaining what services are included and excluded under their Medicare hospice benefit. CMS proposes to require delivery of this document – the Hospice Election Statement Addendum – to all patients at enrollment. By putting the burden of disclosure squarely on the provider, this change should help patients understand their coverage from day one, reducing the confusion that fraudsters can exploit.
What Legitimate Providers Should Do Now
For hospice operators genuinely committed to quality care, these proposals should be more reassuring than alarming. CMS is building a regulatory environment that rewards transparency and penalizes non-disclosure. The most important ways to prepare are also the most straightforward.
Start with compliance. Any hospice not meeting HQRP reporting requirements should address that immediately. The new Care Compare icon will offer an at-a-glance verdict of non-compliance to the public, and the financial consequences are real: non-compliant providers face a net reduction of 4 percentage points to their market basket payment rate update under the proposed rule.
Next, audit your utilization metrics. CMS will build the SSVI from data it already holds. Providers should review their live discharge rates, length of stay trends, care intensity figures, and non-hospice spending now, before scores are published. Any outliers, even those with legitimate clinical explanations, will benefit from additional documentation and internal review before regulators come asking.
Finally, update your intake process. The mandatory election statement addendum will require a process change for most providers. Building a consistent disclosure workflow now demonstrates a commitment to transparency and positions your organization for compliance once the rules take effect.
Providers who plan proactively for these changes will be well-positioned as CMS continues to tighten oversight of the hospice industry. Those who treat the proposed rule as background noise are accepting real risks – to their reimbursement rates, their public profile, and their standing with regulators who are paying increasingly close attention.
.png)
